MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
ClearPoint Neuro Total Assets 2011-2026 | CLPT
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets ClearPoint Neuro
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39.2 M | 42.7 M | 55.5 M | 65.6 M | 29.5 M | 11.9 M | 7.86 M | 13.9 M | 7.4 M | 10.1 M | 13.4 M | 7.87 M | 5.55 M | 3.03 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 65.6 M | 3.03 M | 22.4 M |
Quarterly Total Assets ClearPoint Neuro
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60.4 M | 62.9 M | 30.1 M | 39.2 M | 40.2 M | 52.6 M | 53.6 M | 42.7 M | 43.8 M | 47.6 M | 50.2 M | 55.5 M | 57.7 M | 60.2 M | 61.8 M | 65.6 M | 68.7 M | 72.3 M | 74.3 M | 29.5 M | 29.5 M | 29.5 M | 29.5 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 7.86 M | 7.86 M | 7.86 M | 7.86 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 9.94 M | 9.94 M | 9.94 M | 9.94 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 7.87 M | 7.87 M | 7.87 M | 7.87 M | 5.55 M | 5.55 M | 5.55 M | 5.55 M | 3.03 M | 3.03 M | 3.03 M | 3.03 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 74.3 M | 3.03 M | 25.1 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
204 M | $ 32.81 | 5.67 % | $ 1.45 B |  USA |
 |
Boston Scientific Corporation
BSX
|
39.4 B | $ 98.56 | 0.8 % | $ 145 B | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Abiomed
ABMD
|
1.49 B | - | - | $ 17.2 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
498 M | $ 9.54 | 2.03 % | $ 685 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
776 M | $ 21.96 | 0.76 % | $ 3.14 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
79.2 M | $ 3.47 | -2.49 % | $ 120 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
86.1 M | $ 3.75 | -0.79 % | $ 140 M |  France |
 |
Bio-Rad Laboratories
BIO
|
9.36 B | $ 323.35 | -0.66 % | $ 9.12 B | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
2.31 B | $ 43.31 | -0.39 % | $ 1.34 B | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 53.03 | 0.68 % | $ 7.9 K | USA |
 |
Abbott Laboratories
ABT
|
81.4 B | $ 126.93 | -0.69 % | $ 221 B | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
InMode Ltd.
INMD
|
786 M | $ 15.62 | 0.36 % | $ 1.24 B | Israel |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
473 M | $ 18.33 | -2.19 % | $ 423 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 29.03 | 2.25 % | $ 245 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
LivaNova PLC
LIVN
|
2.51 B | $ 64.55 | 0.66 % | $ 3.5 B |  Britain |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Second Sight Medical Products
EYES
|
41.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
IRadimed Corporation
IRMD
|
98.3 M | $ 97.9 | -0.17 % | $ 1.24 B | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 166.78 | -0.52 % | $ 12.5 B | USA |
 |
Accuray Incorporated
ARAY
|
470 M | $ 0.88 | -1.53 % | $ 90.4 M | USA |
|
LENSAR
LNSR
|
66.3 M | $ 11.53 | 0.7 % | $ 133 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Profound Medical Corp.
PROF
|
43.9 M | $ 8.18 | 5.82 % | $ 180 M | Canada |
 |
FONAR Corporation
FONR
|
199 M | $ 18.55 | 0.03 % | $ 122 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.4 M | $ 1.19 | 0.85 % | $ 19.2 M | USA |
 |
Sintx Technologies
SINT
|
15.4 M | $ 3.84 | 2.95 % | $ 14.3 M | USA |
 |
Globus Medical
GMED
|
5.25 B | $ 90.47 | -3.03 % | $ 12.3 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 13.05 | -0.61 % | $ 1 B | USA |